These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5930 related items for PubMed ID: 3996045

  • 1. Correlation between post-replication repair and metastatic potential in B16 mouse melanoma cell lines.
    Khalil F, Hopp L.
    Cytobios; 1985; 42(166):117-23. PubMed ID: 3996045
    [Abstract] [Full Text] [Related]

  • 2. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS, McLoughlin GA, Richie JP, Mannick JA.
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [Abstract] [Full Text] [Related]

  • 3. Postreplication repair in three murine melanomas, a mammary carcinoma, and a normal mouse lung fibroblast line.
    Hill HZ, Setlow RB.
    Cancer Res; 1980 Jun; 40(6):1867-72. PubMed ID: 7371017
    [Abstract] [Full Text] [Related]

  • 4. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM, Klostergaard J, Granger GA, Nicolson GL.
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [Abstract] [Full Text] [Related]

  • 5. Rate of generation of major karyotypic abnormalities in relationship to the metastatic potential of B16 murine melanoma.
    Kendal WS, Wang RY, Hsu TC, Frost P.
    Cancer Res; 1987 Jul 15; 47(14):3835-41. PubMed ID: 3594440
    [Abstract] [Full Text] [Related]

  • 6. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
    Niles RM, Makarski JS.
    J Natl Cancer Inst; 1978 Aug 15; 61(2):523-6. PubMed ID: 210294
    [Abstract] [Full Text] [Related]

  • 7. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ, Hearn DR.
    Cancer Res; 1983 Nov 15; 43(11):5106-11. PubMed ID: 6616449
    [Abstract] [Full Text] [Related]

  • 8. DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma.
    Usmani BA, Lunec J, Sherbet GV.
    J Cell Biochem; 1993 Mar 15; 51(3):336-44. PubMed ID: 7684740
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M, Moriya S, Shineha R, Satomi S, Miyagi T.
    Acta Biochim Pol; 1998 Mar 15; 45(2):343-9. PubMed ID: 9821865
    [Abstract] [Full Text] [Related]

  • 10. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
    Kure S, Yoshie O, Aso H.
    Jpn J Cancer Res; 1987 Nov 15; 78(11):1238-45. PubMed ID: 2961717
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of a single tropomyosin isoform, TM5/TM30nm, results in reduction in motility of highly metastatic B16-F10 mouse melanoma cells.
    Miyado K, Kimura M, Taniguchi S.
    Biochem Biophys Res Commun; 1996 Aug 14; 225(2):427-35. PubMed ID: 8753779
    [Abstract] [Full Text] [Related]

  • 12. Biophysical identification and sorting of high metastatic variants from B16 melanoma tumor.
    Lessin SR, Abraham SR, Nicolini C.
    Cytometry; 1982 May 14; 2(6):407-13. PubMed ID: 7075401
    [Abstract] [Full Text] [Related]

  • 13. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC, Gordon SG.
    Cancer Res; 1983 Feb 14; 43(2):536-40. PubMed ID: 6848176
    [Abstract] [Full Text] [Related]

  • 14. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T, Gonzalez R, Nicolson GL.
    Cancer Res; 1981 Sep 14; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [Abstract] [Full Text] [Related]

  • 15. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW, Nicolson GL.
    J Supramol Struct; 1979 Sep 14; 11(4):517-28. PubMed ID: 544929
    [Abstract] [Full Text] [Related]

  • 16. Enhanced photoproduct repair: its role in the DNA damage-resistance phenotype of human malignant melanoma cells.
    Hatton DH, Mitchell DL, Strickland PT, Johnson RT.
    Cancer Res; 1995 Jan 01; 55(1):181-9. PubMed ID: 7805031
    [Abstract] [Full Text] [Related]

  • 17. The influence of cell surface properties on the arrest of circulating melanoma cells.
    Poste G.
    Prog Clin Biol Res; 1980 Jan 01; 41():737-45. PubMed ID: 7192863
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G, Doll J, Brown AE, Tzeng J, Zeidman I.
    Cancer Res; 1982 Jul 01; 42(7):2770-8. PubMed ID: 7083167
    [Abstract] [Full Text] [Related]

  • 19. The selection and characterization of an invasive variant of the B16 melanoma.
    Hart IR.
    Am J Pathol; 1979 Dec 01; 97(3):587-600. PubMed ID: 507192
    [Abstract] [Full Text] [Related]

  • 20. Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants.
    Niles RM, Makarski JS.
    J Cell Physiol; 1978 Sep 01; 96(3):355-9. PubMed ID: 209054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 297.